277 related articles for article (PubMed ID: 17762441)
1. Dose escalation for patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone.
Yeh SA; Huang YJ
Am J Clin Oncol; 2007 Aug; 30(4):401-5. PubMed ID: 17762441
[TBL] [Abstract][Full Text] [Related]
2. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
3. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors.
Oksüz DC; Meral G; Uzel O; Cağatay P; Turkan S
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):388-94. PubMed ID: 15380570
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.
Kwong DL; Sham JS; Leung LH; Cheng AC; Ng WM; Kwong PW; Lui WM; Yau CC; Wu PM; Wei W; Au G
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):374-81. PubMed ID: 16213105
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
[TBL] [Abstract][Full Text] [Related]
7. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone.
Yeh SA; Tang Y; Lui CC; Huang YJ; Huang EY
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):672-9. PubMed ID: 15936544
[TBL] [Abstract][Full Text] [Related]
9. [Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer].
Xie CY; Wu SX; Jin XC; Yu JY; Wang JH; Li WF; Zhang P
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2412-5. PubMed ID: 18036320
[TBL] [Abstract][Full Text] [Related]
10. 10-year survival rate for patient with nasopharyngeal carcinoma after radiation therapy. Clinical analysis of 367 cases.
Chen CQ; Liu TF; Zhao S
Chin Med J (Engl); 1989 Apr; 102(4):239-42. PubMed ID: 2507236
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
13. [Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma].
Lu TX; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Zeng ZF; Huang SM; Lin CG; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):386-9. PubMed ID: 12921573
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in nasopharyngeal carcinoma in childhood and adolescence].
Cao KJ; Li Y; Xie GF; Hong MH
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):134-7. PubMed ID: 16750020
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
[TBL] [Abstract][Full Text] [Related]
16. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
[TBL] [Abstract][Full Text] [Related]
17. [Impact of dose boost in skull base on recurrence of stage T4 nasopharyngeal carcinoma].
Xie GF; Cao KJ; Li Y; Huang PY
Ai Zheng; 2005 Oct; 24(10):1246-8. PubMed ID: 16219141
[TBL] [Abstract][Full Text] [Related]
18. Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy.
Palazzi M; Guzzo M; Tomatis S; Cerrotta A; Potepan P; Quattrone P; Cantù G
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1451-8. PubMed ID: 15590176
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy in the treatment of tumors of the nasopharynx in advanced stage].
Donato V; Maurizi Enrici R; Banelli E; Cerqua M; Falchetto Osti M; Santarelli M; Vitturini A
Radiol Med; 1990 Oct; 80(4):506-9. PubMed ID: 2244040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]